Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6931
Reference
MSAN(2020)45
Name
Zyban® (bupropion hydrochloride) 150mg prolonged release tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Zyban® (bupropion hydrochloride) 150mg prolonged release tablets will be out of stock from week commencing 15th June 2020 until the end of November 2020.
2. Unlicensed supplies of bupropion 150mg prolonged release tablets have been sourced.
3. Champix® (varenicline tartrate) tablets, which are licensed for the treatment of nicotine dependence, are available.
4. Various nicotine replacement therapies (NRT) are also available.
2. Unlicensed supplies of bupropion 150mg prolonged release tablets have been sourced.
3. Champix® (varenicline tartrate) tablets, which are licensed for the treatment of nicotine dependence, are available.
4. Various nicotine replacement therapies (NRT) are also available.
Contact Name
Contact Email
Contact Address
Created
2020-06-01 00:00:00
Click to go back to homepage